Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	latrotoxin receptor activity	ADGRL1 ADGRL2	3.17e-05	2	113	2	GO:0016524
Domain	Latrophilin	ADGRL1 ADGRL2	1.01e-04	3	109	2	PF02354
Domain	GPCR_2_latrophilin_rcpt_C	ADGRL1 ADGRL2	1.01e-04	3	109	2	IPR003334
Domain	COE	EBF3 EBF1	2.01e-04	4	109	2	PS01345
Domain	Transcription_factor_COE	EBF3 EBF1	2.01e-04	4	109	2	IPR003523
Domain	COE_HLH	EBF3 EBF1	2.01e-04	4	109	2	IPR032201
Domain	COE_DBD	EBF3 EBF1	2.01e-04	4	109	2	IPR032200
Domain	Transcription_factor_COE_CS	EBF3 EBF1	2.01e-04	4	109	2	IPR018350
Domain	COE1_HLH	EBF3 EBF1	2.01e-04	4	109	2	PF16423
Domain	COE1_DBD	EBF3 EBF1	2.01e-04	4	109	2	PF16422
Domain	Gal_Lectin	ADGRL1 ADGRL2	3.34e-04	5	109	2	PF02140
Domain	GPCR_2_latrophilin	ADGRL1 ADGRL2	3.34e-04	5	109	2	IPR003924
Domain	Mtc	SFXN1 SFXN3	3.34e-04	5	109	2	PF03820
Domain	Lectin_gal-bd_dom	ADGRL1 ADGRL2	3.34e-04	5	109	2	IPR000922
Domain	SUEL_LECTIN	ADGRL1 ADGRL2	3.34e-04	5	109	2	PS50228
Domain	Mtc	SFXN1 SFXN3	3.34e-04	5	109	2	IPR004686
Domain	CUE	AMFR TAB2	6.95e-04	7	109	2	SM00546
Domain	Desmosomal_cadherin	DSC3 DSG3	6.95e-04	7	109	2	IPR009122
Pubmed	Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia.	MYT1L AKAP6 CENPF TAB2 ZNF490 CCSER2 KIF5B SOS1	3.65e-08	151	113	8	17043677
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	KDM5C DIDO1 RAD54L2 SRRT USP5 MDN1 XPO5 KIF5B DNMT1	1.48e-06	332	113	9	32786267
Pubmed	Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.	DHX57 AGPS SFXN1 SRRT XPO5 NMT2 PLCG1 KIF5B UBE3C DBR1 PLOD1 DNMT1	1.53e-06	653	113	12	33742100
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	ANKFY1 DSC3 DHX57 OAS3 AGPS SFXN1 SRRT LIG3 USP5 MDN1 SFXN3 ASPM PLCG1 KIF5B PLOD1 PHLDB2 DNMT1	1.80e-06	1353	113	17	29467282
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	VAPA DLG5 SP100 DSC3 DSG3 CENPF INPP5K DIDO1 OAS3 SFXN1 SRRT KIF5B UHRF2 SNTB2 PHLDB2 DNMT1	3.17e-06	1257	113	16	36526897
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	VAPA ANKFY1 CENPF DYNC2H1 AGPS OGDH SFXN1 SRRT LIG3 MDN1 CLCA2 XPO5 SFXN3 PLCG1 KIF5B UBE3C DNMT1	3.60e-06	1425	113	17	30948266
Pubmed	Drafting the CLN3 protein interactome in SH-SY5Y human neuroblastoma cells: a label-free quantitative proteomics approach.	SFXN1 FBXO6 XPO5 SFXN3 ADGRL2	4.17e-06	73	113	5	23464991
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	CENPF ZKSCAN8 DIDO1 DHX57 OGDH SFXN1 SRRT LIG3 MDN1 ASPM UBE3C DNMT1	7.08e-06	759	113	12	35915203
Pubmed	SUMOylation regulates USP5-Cav3.2 calcium channel interactions.	USP5 CACNA1H	1.05e-05	2	113	2	31455361
Pubmed	A cell-permeant peptide corresponding to the cUBP domain of USP5 reverses inflammatory and neuropathic pain.	USP5 CACNA1H	1.05e-05	2	113	2	27130589
Pubmed	Deficiency of the syntrophins and alpha-dystrobrevin in patients with inherited myopathy.	DTNA SNTB2	1.05e-05	2	113	2	12899872
Pubmed	Direct interaction of SOS1 Ras exchange protein with the SH3 domain of phospholipase C-gamma1.	PLCG1 SOS1	1.05e-05	2	113	2	10913276
Pubmed	Disrupting USP5/Cav3.2 interactions protects female mice from mechanical hypersensitivity during peripheral inflammation.	USP5 CACNA1H	1.05e-05	2	113	2	30340616
Pubmed	Small organic molecule disruptors of Cav3.2 - USP5 interactions reverse inflammatory and neuropathic pain.	USP5 CACNA1H	1.05e-05	2	113	2	25889575
Pubmed	Altered expression of desmocollin 3, desmoglein 3, and beta-catenin in oral squamous cell carcinoma: correlation with lymph node metastasis and cell proliferation.	DSC3 DSG3	1.05e-05	2	113	2	17846785
Pubmed	The deubiquitinating enzyme USP5 modulates neuropathic and inflammatory pain by enhancing Cav3.2 channel activity.	USP5 CACNA1H	1.05e-05	2	113	2	25189210
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	VAPA AMFR DYNC2H1 RDH14 SFXN1 USP5 SPINT2 XPO5 KIF5B ADGRL2 PLOD1 WNK3 DNMT1	1.23e-05	942	113	13	31073040
Pubmed	Elucidation of the BMI1 interactome identifies novel regulatory roles in glioblastoma.	VAPA DLG5 DIDO1 SFXN1 SRRT PLCG1 KIF5B PLOD1	1.27e-05	329	113	8	34316702
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	MYT1L ANKFY1 EBF3 KDM5C ING5 ZKSCAN8 DIDO1 EBF1 ONECUT1 PLCG1 UHRF2 DNMT1	1.32e-05	808	113	12	20412781
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	SP100 RBL1 KDM5C INPP5K ING5 OAS3 ITGA3 SULF2 CBY2 ASPM ADGRL2 PHLDB2 KNL1 SOS1	1.62e-05	1116	113	14	31753913
Pubmed	The Genetic Basis of Baculum Size and Shape Variation in Mice.	RBL1 ASPM PLCG1	1.81e-05	16	113	3	26935419
Pubmed	Prediction of the coding sequences of unidentified human genes. XV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	ANKFY1 ZNF490 SULF2 XPO5 ATAD2B	2.25e-05	103	113	5	10574462
Pubmed	A family of heptahelical receptors with adhesion-like domains: a marriage between two super families.	ADGRL1 ADGRL2	3.13e-05	3	113	2	10994649
Pubmed	Aberrant MFN2 transcription facilitates homocysteine-induced VSMCs proliferation via the increased binding of c-Myc to DNMT1 in atherosclerosis.	MFN2 DNMT1	3.13e-05	3	113	2	31104361
Pubmed	Identification of interleukin-1 beta as a key mediator in the upregulation of Cav3.2-USP5 interactions in the pain pathway.	USP5 CACNA1H	3.13e-05	3	113	2	28741432
Pubmed	Reduced fibulin-2 contributes to loss of basement membrane integrity and skin blistering in mice lacking integrin α3β1 in the epidermis.	ITGA3 FBLN2	3.13e-05	3	113	2	24390135
Pubmed	The characterization of the Olf-1/EBF-like HLH transcription factor family: implications in olfactory gene regulation and neuronal development.	EBF3 EBF1	3.13e-05	3	113	2	9151732
Pubmed	Differential regulation of HMG-CoA reductase and Insig-1 by enzymes of the ubiquitin-proteasome system.	AMFR HMGCR	3.13e-05	3	113	2	23087214
Pubmed	DNMT1/miR-152-3p/SOS1 signaling axis promotes self-renewal and tumor growth of cancer stem-like cells derived from non-small cell lung cancer.	DNMT1 SOS1	3.13e-05	3	113	2	38622665
Pubmed	The ABCA1 cholesterol transporter associates with one of two distinct dystrophin-based scaffolds in Schwann cells.	DTNA SNTB2	3.13e-05	3	113	2	18286648
Pubmed	The multiple actions of black widow spider toxins and their selective use in neurosecretion studies.	ADGRL1 ADGRL2	3.13e-05	3	113	2	15066411
Pubmed	Low to high Ca2+ -switch causes phosphorylation and association of desmocollin 3 with plakoglobin and desmoglein 3 in cultured keratinocytes.	DSC3 DSG3	3.13e-05	3	113	2	19348003
Pubmed	Dystrobrevin dynamics in muscle-cell signalling: a possible target for therapeutic intervention in Duchenne muscular dystrophy?	DTNA SNTB2	3.13e-05	3	113	2	12206805
Pubmed	Regulation of mitophagy by the Gp78 E3 ubiquitin ligase.	AMFR MFN2	3.13e-05	3	113	2	23427266
Pubmed	alpha-Latrotoxin and its receptors: neurexins and CIRL/latrophilins.	ADGRL1 ADGRL2	3.13e-05	3	113	2	11520923
Pubmed	Regulation of fibulin-2 gene expression by integrin α3β1 contributes to the invasive phenotype of transformed keratinocytes.	ITGA3 FBLN2	3.13e-05	3	113	2	24694902
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	ANKFY1 ACACB DYNC2H1 TAB2 ITGA3 ABCC6 LIG3 MDN1 SNTB2 KNL1	4.59e-05	638	113	10	31182584
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	DLG5 EBF3 ZKSCAN8 DIDO1 DHX57 AGPS OGDH SFXN1 SRRT LIG3 SULF2 SFXN3 PLOD1	5.16e-05	1082	113	13	38697112
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	CENPF DIDO1 DHX57 USP5 MDN1 XPO5 ATAD2B KIF5B PLOD1 DNMT1	5.57e-05	653	113	10	22586326
Pubmed	The MYO6 interactome reveals adaptor complexes coordinating early endosome and cytoskeletal dynamics.	VAPA FRMD6 CCSER2 SNTB2 PHLDB2	5.70e-05	125	113	5	29467281
Pubmed	TRPV1 Nociceptor Activity Initiates USP5/T-type Channel-Mediated Plasticity.	USP5 CACNA1H	6.25e-05	4	113	2	27974205
Pubmed	Cloning and functional characterization of Roaz, a zinc finger protein that interacts with O/E-1 to regulate gene expression: implications for olfactory neuronal development.	EBF3 EBF1	6.25e-05	4	113	2	9151733
Pubmed	Cloning of a novel Olf-1/EBF-like gene, O/E-4, by degenerate oligo-based direct selection.	EBF3 EBF1	6.25e-05	4	113	2	12139918
Pubmed	Subsets of epidermal growth factor receptors during activation and endocytosis.	PLCG1 SOS1	6.25e-05	4	113	2	9020117
Pubmed	LEK1 is a potential inhibitor of pocket protein-mediated cellular processes.	CENPF RBL1	6.25e-05	4	113	2	14555653
Pubmed	Gp78, a membrane-anchored ubiquitin ligase, associates with Insig-1 and couples sterol-regulated ubiquitination to degradation of HMG CoA reductase.	AMFR HMGCR	6.25e-05	4	113	2	16168377
Pubmed	Engagement of the T lymphocyte antigen receptor regulates association of son-of-sevenless homologues with the SH3 domain of phospholipase Cgamma1.	PLCG1 SOS1	6.25e-05	4	113	2	10940929
Pubmed	GRB2 and phospholipase C-gamma 1 associate with a 36- to 38-kilodalton phosphotyrosine protein after T-cell receptor stimulation.	PLCG1 SOS1	6.25e-05	4	113	2	7516467
Pubmed	Global mapping of herpesvirus-host protein complexes reveals a transcription strategy for late genes.	DSC3 RBL1 OGDH LIG3 ASPM UBE3C PLOD1 KNL1 DNMT1	6.35e-05	533	113	9	25544563
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	VAPA AMFR ING5 DHX57 OAS3 HMGCR OGDH LIG3 USP5 MDN1 FBXO6 XPO5 UBE3C ADGRL2 PLOD1	6.73e-05	1440	113	15	30833792
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	ANKFY1 CENPF EBF3 DIDO1 ARHGEF11 MDN1 SFXN3 MFN2 KIF5B WNK3 PHLDB2 DNMT1	7.23e-05	963	113	12	28671696
Pubmed	Mutation specific functions of EGFR result in a mutation-specific downstream pathway activation.	VAPA PLCG1 UBE3C SOS1	7.33e-05	68	113	4	25754235
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	VAPA AMFR DTNA PPEF1 USP5 XPO5 SFXN3 PLCG1 UBE3C ADGRL2 PLOD1 SNTB2	8.05e-05	974	113	12	28675297
Pubmed	Blood pressure is regulated by an alpha1D-adrenergic receptor/dystrophin signalosome.	AMFR DTNA SNTB2	9.23e-05	27	113	3	18468998
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	MYT1L AKAP6 ANKFY1 TAB2 SULF2 XPO5	9.74e-05	225	113	6	12168954
Pubmed	Formation of whisker-related principal sensory nucleus-based lemniscal pathway requires a paired homeodomain transcription factor, Drg11.	EBF3 EBF1	1.04e-04	5	113	2	12917357
Pubmed	Dnmt1-dependent Chk1 pathway suppression is protective against neuron division.	RBL1 DNMT1	1.04e-04	5	113	2	28928282
Pubmed	SFXN1 is a mitochondrial serine transporter required for one-carbon metabolism.	SFXN1 SFXN3	1.04e-04	5	113	2	30442778
Pubmed	Ligation of the T-cell antigen receptor (TCR) induces association of hSos1, ZAP-70, phospholipase C-gamma 1, and other phosphoproteins with Grb2 and the zeta-chain of the TCR.	PLCG1 SOS1	1.04e-04	5	113	2	7629168
Pubmed	Nomenclature of the desmosomal cadherins.	DSC3 DSG3	1.04e-04	5	113	2	8486729
Pubmed	Expression patterns of the coe/ebf transcription factor genes during chicken and mouse limb development.	EBF3 EBF1	1.04e-04	5	113	2	15261831
Pubmed	The fate of desmosomal proteins in apoptotic cells.	DSC3 DSG3	1.04e-04	5	113	2	11500511
Pubmed	Sterol-induced degradation of HMG CoA reductase depends on interplay of two Insigs and two ubiquitin ligases, gp78 and Trc8.	AMFR HMGCR	1.04e-04	5	113	2	22143767
Pubmed	Discoidin domain receptor 1 (DDR1) signaling in PC12 cells: activation of juxtamembrane domains in PDGFR/DDR/TrkA chimeric receptors.	PLCG1 SOS1	1.04e-04	5	113	2	10783152
Pubmed	Differential association of syntrophin pairs with the dystrophin complex.	DTNA SNTB2	1.04e-04	5	113	2	9214383
Pubmed	Stem cell niche-specific Ebf3 maintains the bone marrow cavity.	EBF3 EBF1	1.04e-04	5	113	2	29563184
Pubmed	A phospholipase C-γ1-independent, RasGRP1-ERK-dependent pathway drives lymphoproliferative disease in linker for activation of T cells-Y136F mutant mice.	PLCG1 SOS1	1.04e-04	5	113	2	23209318
Pubmed	Prognosis of young ischemic stroke in Taiwan: impact of prothrombotic genetic polymorphisms.	ITGA3 F7	1.04e-04	5	113	2	15351855
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	CENPF RAD54L2 SRRT LIG3 MDN1 SFXN3 DBR1 KNL1	1.21e-04	453	113	8	29656893
Pubmed	LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow.	OAS3 ARHGEF11 OGDH USP5 MDN1 PLCG1 KIF5B	1.37e-04	344	113	7	30333137
Pubmed	Embryonic forebrain transcriptome of mice with polyalanine expansion mutations in the ARX homeobox gene.	MYT1L EBF1 ASPM	1.40e-04	31	113	3	27798109
Pubmed	Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.	VAPA DLG5 DSC3 OAS3 AGPS OGDH SFXN1 USP5 SFXN3 KIF5B PLOD1 PHLDB2 KNL1 DNMT1	1.43e-04	1367	113	14	32687490
Pubmed	Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.	DLG5 ACACB KDM5C HMGCR MFN2 KNL1	1.45e-04	242	113	6	34011540
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	VAPA AMFR SP100 PCDHB5 ZKSCAN8 TAB2 ITGA3 AGPS ONECUT1 XPO5 CCSER2 MFN2 PLOD1	1.49e-04	1203	113	13	29180619
Pubmed	M phase phosphorylation of the epigenetic regulator UHRF1 regulates its physical association with the deubiquitylase USP7 and stability.	UHRF2 DNMT1	1.56e-04	6	113	2	22411829
Pubmed	Family of Ebf/Olf-1-related genes potentially involved in neuronal differentiation and regional specification in the central nervous system.	EBF3 EBF1	1.56e-04	6	113	2	9389446
Pubmed	FGF signal transduction in PC12 cells: comparison of the responses induced by endogenous and chimeric receptors.	PLCG1 SOS1	1.56e-04	6	113	2	9797459
Pubmed	Analysis of tyrosine phosphorylation-dependent interactions between stimulatory effector proteins and the B cell co-receptor CD22.	PLCG1 SOS1	1.56e-04	6	113	2	10373493
Pubmed	The three human syntrophin genes are expressed in diverse tissues, have distinct chromosomal locations, and each bind to dystrophin and its relatives.	DTNA SNTB2	1.56e-04	6	113	2	8576247
Pubmed	Ancient ubiquitous protein-1 mediates sterol-induced ubiquitination of 3-hydroxy-3-methylglutaryl CoA reductase in lipid droplet-associated endoplasmic reticulum membranes.	AMFR HMGCR	1.56e-04	6	113	2	23223569
Pubmed	The transcription factor, Lmx1b, is necessary for the development of the principal trigeminal nucleus-based lemniscal pathway.	EBF3 EBF1	1.56e-04	6	113	2	20621716
Pubmed	Hierarchical expression of desmosomal cadherins during stratified epithelial morphogenesis in the mouse.	DSC3 DSG3	1.56e-04	6	113	2	9404003
Pubmed	The calcium-independent receptor for alpha-latrotoxin from human and rodent brains interacts with members of the ProSAP/SSTRIP/Shank family of multidomain proteins.	ADGRL1 ADGRL2	1.56e-04	6	113	2	10964907
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	DLG5 SP100 DSC3 CENPF DIDO1 ASPM PRMT7 KNL1	1.60e-04	472	113	8	38943005
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	VAPA AMFR DHX57 GPRIN3 SRRT NMT2 FMNL1 DNMT1	1.67e-04	475	113	8	31040226
Pubmed	Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM.	KDM5C PRMT7 DNMT1	1.70e-04	33	113	3	26864203
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	ZKSCAN8 DIDO1 OGDH LIG3 USP5 KIF5B DBR1	1.81e-04	360	113	7	33111431
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	VAPA ANKFY1 RBL1 DTNA NMT2 PLCG1 CPLANE1 PLOD1 SNTB2 KNL1 SOS1	1.91e-04	910	113	11	36736316
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	DLG5 CENPF DIDO1 ASPM KIF5B KNL1	1.96e-04	256	113	6	33397691
Pubmed	TGFβ attenuates cartilage extracellular matrix degradation via enhancing FBXO6-mediated MMP14 ubiquitination.	DSC3 ITGA3 SULF2 FBXO6 PLOD1	2.04e-04	164	113	5	32409323
Pubmed	Ebf factors and MyoD cooperate to regulate muscle relaxation via Atp2a1.	EBF3 EBF1	2.17e-04	7	113	2	24786561
Pubmed	PML-like subnuclear bodies, containing XRCC1, juxtaposed to DNA replication-based single-strand breaks.	SP100 LIG3	2.17e-04	7	113	2	30260704
Pubmed	S phase-dependent interaction with DNMT1 dictates the role of UHRF1 but not UHRF2 in DNA methylation maintenance.	UHRF2 DNMT1	2.17e-04	7	113	2	22064703
Pubmed	Erythropoietin receptor Y479 couples to ERK1/2 activation via recruitment of phospholipase Cgamma.	PLCG1 SOS1	2.17e-04	7	113	2	15953601
Pubmed	Alpha-dystrobrevin-1 recruits alpha-catulin to the alpha1D-adrenergic receptor/dystrophin-associated protein complex signalosome.	DTNA SNTB2	2.17e-04	7	113	2	21115837
Pubmed	E2F-5, a new E2F family member that interacts with p130 in vivo.	RBL1 DNMT1	2.17e-04	7	113	2	7760804
Pubmed	PTPRA Phosphatase Regulates GDNF-Dependent RET Signaling and Inhibits the RET Mutant MEN2A Oncogenic Potential.	GPRIN3 SPINT2 PLCG1 SOS1	2.57e-04	94	113	4	32062451
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	AMFR EBF3 INPP5K PCDHB5 DHX57 SFXN1 SRRT LIG3 FRMD6 XPO5 ASPM KIF5B POLQ	2.80e-04	1284	113	13	17353931
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	RBL1 DIDO1 DHX57 RAD54L2 SRRT LIG3 SULF2 DBR1 DNMT1	2.80e-04	650	113	9	38777146
Pubmed	Genetic disruptions of O/E2 and O/E3 genes reveal involvement in olfactory receptor neuron projection.	EBF3 EBF1	2.89e-04	8	113	2	14993187
Cytoband	1p36.22	FBXO6 MFN2 PLOD1	1.06e-04	37	113	3	1p36.22
GeneFamily	PHD finger proteins	SP100 KDM5C ING5 DIDO1 UHRF2	3.14e-05	90	73	5	88
GeneFamily	Adhesion G protein-coupled receptors, subfamily L	ADGRL1 ADGRL2	9.60e-05	4	73	2	918
GeneFamily	Sideroflexins	SFXN1 SFXN3	1.60e-04	5	73	2	746
GeneFamily	Desmosomal cadherins	DSC3 DSG3	3.33e-04	7	73	2	1188
GeneFamily	PDZ domain containing	DLG5 ARHGEF11 RHPN1 SNTB2	3.33e-03	152	73	4	1220
Coexpression	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP	VAPA SP100 ASZ1 CYP21A2 OAS3 HMGCR LIG3 TLR3 CCSER2 CHAC1 PHLDB2 DNMT1	5.79e-06	567	112	12	M1097
Coexpression	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP	VAPA SP100 ASZ1 CYP21A2 OAS3 HMGCR LIG3 TLR3 CCSER2 CHAC1 PHLDB2 DNMT1	1.33e-05	616	112	12	MM977
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_basal-Basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DLG5 DSC3 DSG3 SULT1E1 CROT SULF2 FRMD6 ADGRL2	3.77e-08	197	112	8	1e915957ea6a4550ecb9d6ee4b232aa5800faf20
ToppCell	distal-1-Epithelial-Proliferating_Basal\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MAGEA10 DSC3 DSG3 CENPF SULT1E1 CLCA2 ASPM KNL1	4.08e-08	199	112	8	93450257180d918c310bca7b5defc74390c48091
ToppCell	distal-Epithelial-Proliferating_Basal\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MAGEA10 DSC3 DSG3 CENPF SULT1E1 CLCA2 ASPM KNL1	4.24e-08	200	112	8	25cc494ef831511840d8c02ec1bd086635cc7edd
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_basal-Basal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	HCAR2 DSC3 DSG3 ITGA3 SULT1E1 CROT SPINT2 CLCA2	4.24e-08	200	112	8	9da214f756a03516eaafde00289b90f69623b9f3
ToppCell	distal-Epithelial-Proliferating_Basal-1\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MAGEA10 DSC3 DSG3 CENPF SULT1E1 CLCA2 ASPM KNL1	4.24e-08	200	112	8	cc31e8c28d01e6757c5dd7f485db6acf7409a47e
ToppCell	TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma\|TCGA-Cervix / Sample_Type by Project: Shred V9	HCAR2 DSC3 DSG3 DUS2 CLCA2 FRMD6 PHLDB2	3.19e-07	176	112	7	8513c2a05a34453a16bbcf1c11cb34c580133e47
ToppCell	kidney_cells-Adult_normal_reference-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CENPF RBL1 ASPM POLQ FMNL1 KNL1 DNMT1	5.34e-07	190	112	7	b65383e256b04122500b742caeed0b807793851e
ToppCell	kidney_cells-Adult_normal_reference-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CENPF RBL1 ASPM POLQ FMNL1 KNL1 DNMT1	5.34e-07	190	112	7	89095d3e023269d89c82e3a73550f869e3f34201
ToppCell	PSB-critical-LOC-Epithelial-Basal\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DSC3 SULT1E1 CROT SULF2 CLCA2 FRMD6 PHLDB2	7.29e-07	199	112	7	2add64c3e4cb6384ec381f34c3f1f77e13e3f27c
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_basal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	HCAR2 DSC3 DSG3 ITGA3 CROT SPINT2 CLCA2	7.54e-07	200	112	7	2a9d715aba8bdef2341b0d44ff60825c074a4b03
ToppCell	LPS_only-Endothelial-Endothelial-FOXM1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CENPF GFRA3 SFXN1 ASPM DBR1 KNL1	1.15e-06	134	112	6	4d8f7ddad02fe76a614771e115ebb8e04623ba85
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HCAR2 CENPF SSX7 ASPM POLQ KNL1	5.23e-06	174	112	6	84da9faff088d05233183b425385beb054c92d1b
ToppCell	moderate-Myeloid-Mast_cell\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	ADGRL1 GFRA3 FBLN2 TIE1 NMT2 WNK3	5.40e-06	175	112	6	bbd2971bc6d69e507f90a637834d0936c205c590
ToppCell	COVID-19_Convalescent-Classical_Monocyte-cMono_4\|Classical_Monocyte / Disease condition and Cell class	DHX57 GPRIN3 HMGCR PCNX2 USP5 MDN1	6.15e-06	179	112	6	9d51318ac198a8801bd5c7031ebf2b0c74ffeeb6
ToppCell	COVID-19_Convalescent-Classical_Monocyte-cMono_4\|COVID-19_Convalescent / Disease condition and Cell class	DHX57 GPRIN3 HMGCR PCNX2 USP5 MDN1	6.15e-06	179	112	6	366e4a31db9e80fd1770ac9f1ae148fefeb9f7df
ToppCell	PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYT1L CENPF TIE1 ASPM ADGRL2 KNL1	6.35e-06	180	112	6	b35a8c6169f4b548b912af005e92ae7c6596f376
ToppCell	critical-Myeloid-Mast_cell\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	GFRA3 FBLN2 TIE1 NMT2 CACNA1H WNK3	6.56e-06	181	112	6	f0d81ae74d3f32979624a94b2ef93774831a7970
ToppCell	droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CENPF RBL1 F7 SULF2 ASPM KNL1	7.43e-06	185	112	6	57c1eb50a4456d20953e48d5dc3b0ea3d0d81b6d
ToppCell	Control-T_cells-Cycling_NK/T_cells\|Control / group, cell type (main and fine annotations)	CENPF RBL1 ASPM POLQ UHRF2 KNL1	7.43e-06	185	112	6	9766216b41ee62bbac4caa25cb98ec5627a24075
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CENPF CLCA2 NMT2 ASPM KNL1 DNMT1	7.66e-06	186	112	6	15ab6666748a641226e42e6ca6eeaf186a501c95
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CENPF CLCA2 NMT2 ASPM KNL1 DNMT1	7.66e-06	186	112	6	4ed1b97e2552f3c4134f25665d7513498ffac16c
ToppCell	COVID-19-Fibroblasts-Airway_smooth_muscle\|COVID-19 / group, cell type (main and fine annotations)	AKAP6 DTNA EBF1 MYOCD CACNA1H PHLDB2	7.90e-06	187	112	6	464a0c3b92b778911b5f9cd73642e09e3472063a
ToppCell	droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-25\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CYP21A2 EBF1 SULT1E1 FBLN2 SULF2 RORB	7.90e-06	187	112	6	0d4b7da81036c2aa678654b9fe49c939d08fcd9b
ToppCell	RV-04._Ventricular_Cardiomyocyte_I\|World / Chamber and Cluster_Paper	AKAP6 ACACB DTNA MYOCD TMEM178B ADGRL2	7.90e-06	187	112	6	78cdcf8bc141d3b155c3c8af908431fc419c4d08
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|World / Chamber and Cluster_Paper	AKAP6 ACACB DTNA MYOCD TMEM178B ADGRL2	8.14e-06	188	112	6	0758b474457efa36488e0195f7357100f4b6a090
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	AKAP6 ACACB DTNA MYOCD TMEM178B ADGRL2	8.39e-06	189	112	6	5e80c47f63980904c4c1ff02c201b67b456a0974
ToppCell	TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma\|TCGA-Cervix / Sample_Type by Project: Shred V9	HCAR2 DSC3 DSG3 CLCA2 FRMD6 MFN2	8.39e-06	189	112	6	533c302df467d13ab639232daf4f8cafb808260b
ToppCell	IPF-Epithelial-Basal\|IPF / Disease state, Lineage and Cell class	DSC3 DSG3 ITGA3 CLCA2 FRMD6 PHLDB2	8.65e-06	190	112	6	ea19e9ce954f2dfde97388db9695325cd92ab88f
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	AKAP6 ACACB DTNA MYOCD TMEM178B ADGRL2	8.65e-06	190	112	6	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|LV / Chamber and Cluster_Paper	AKAP6 ACACB DTNA MYOCD TMEM178B ADGRL2	9.18e-06	192	112	6	ad19e2c1d36a0566c9b12ced10db78f4781c8ea6
ToppCell	RA-03._Atrial_Cardiomyocyte\|RA / Chamber and Cluster_Paper	AKAP6 ACACB DTNA MYOCD TMEM178B ADGRL2	9.74e-06	194	112	6	c3535f7cc0076653c72db582047cff053c322397
ToppCell	facs-Thymus-nan-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CENPF RBL1 ASPM POLQ KNL1 DNMT1	1.00e-05	195	112	6	93c345e70d6c8ff5d12fd63d73228c1700b804a0
ToppCell	LPS_only-Endothelial-Endothelial-FOXM1\|LPS_only / Treatment groups by lineage, cell group, cell type	CENPF DHX57 NMT2 ASPM POLQ KNL1	1.06e-05	197	112	6	038fd92750257d43d5e980fd06d77742b543f11a
ToppCell	severe-Myeloid-Immature_Neutrophils_2\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	CENPF RBL1 ASPM POLQ KNL1 DNMT1	1.09e-05	198	112	6	e36303628af3139310c1d7a84d2919b7319bbda4
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DSC3 DSG3 CENPF CLCA2 ASPM POLQ	1.09e-05	198	112	6	f088badb90c6c2d916195f5649eda102119c9ac6
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_basal-Suprabasal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DLG5 DSC3 DSG3 CLCA2 FRMD6 TMEM178B	1.13e-05	199	112	6	f5c3561744e2a0e7716657cb521acb1d8f054b41
ToppCell	Biopsy_IPF-Epithelial-Basal\|Biopsy_IPF / Sample group, Lineage and Cell type	DSC3 DSG3 CROT SPINT2 CLCA2 FRMD6	1.16e-05	200	112	6	5cea84581201cee7ba8141b96e65864f4fd67113
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DLG5 DSC3 DSG3 SULT1E1 CROT FRMD6	1.16e-05	200	112	6	8827653738a931e4a4545e0c7d75be12bed40740
ToppCell	LPS-antiTNF-Unknown-Endothelial-Pericyte_2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CENPF EBF1 INSC ASPM POLQ	2.10e-05	132	112	5	02491930097b75aaeedab9e8200711b0dc610944
ToppCell	TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular\|TCGA-Stomach / Sample_Type by Project: Shred V9	CENPF RHPN1 XPO5 ASPM POLQ	2.60e-05	138	112	5	93497c0a5d5e54006653b2dedc7a7041e1a613e6
ToppCell	droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RBL1 CHAC1 OPLAH	3.74e-05	26	112	3	e2db677bc0f2011883c8b44058276ecf879d4303
ToppCell	droplet-Lung-18m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DHX57 LIG3 MDN1 TTLL4 KNL1	3.76e-05	149	112	5	65778f19599b4955c0a16f0121237656449431fb
ToppCell	facs-Marrow-B-cells-3m-Lymphocytic-BM_CD8_+_CD4_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYT1L ADGRL1 DHX57 TLR3 CPLANE1	5.27e-05	160	112	5	55f599df6e3b7a5a505df4b094c834281311d94a
ToppCell	RV-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	EBF1 ITGA3 FZD9 SPINT2 CACNA1H	5.27e-05	160	112	5	29c9b4770d0e73d59cffc7937b179484c76b6dcc
ToppCell	TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Epitheliod-2\|TCGA-Mesothelium / Sample_Type by Project: Shred V9	SP100 ACACB KRT39 TLR3 PRMT7	5.27e-05	160	112	5	d288b0a315f6adc0be4bdc89fa67bf93679a743f
ToppCell	facs-Marrow-B-cells-3m-Lymphocytic-mature_alpha-beta_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYT1L ADGRL1 DHX57 TLR3 CPLANE1	5.27e-05	160	112	5	296e53e1e0786346d38db2d4188b9a1c0430627b
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CENPF PCDHB5 FRMD6 ASPM POLQ	5.43e-05	161	112	5	a7e09cf2ca6cd70d40d08440fe9c5ab9befa1b79
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CENPF PCDHB5 FRMD6 ASPM POLQ	5.43e-05	161	112	5	08920a716f6ec62538e361211455a30ad726d7be
ToppCell	critical-Myeloid-Mast_cell\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	GFRA3 FBLN2 TIE1 NMT2 CACNA1H	6.10e-05	165	112	5	34a1cc6ccd46c059354e8fbde1ac69f202695a4e
ToppCell	moderate-Myeloid-Mast_cell\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	ADGRL1 GFRA3 TIE1 NMT2 WNK3	6.28e-05	166	112	5	c3835b424c63bf11a4e2c47635dc3787fc4a637a
ToppCell	Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)\|Cerebellum / BrainAtlas - Mouse McCarroll V32	RBL1 TRIM6 ABCC6 CLCA2	6.31e-05	85	112	4	bb9555652e93620d5aeeb71e915b3978a437407d
ToppCell	Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)--\|Cerebellum / BrainAtlas - Mouse McCarroll V32	RBL1 TRIM6 ABCC6 CLCA2	6.31e-05	85	112	4	f7935c3206310adafdecb75149c3b06c38e7780c
ToppCell	Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)-\|Cerebellum / BrainAtlas - Mouse McCarroll V32	RBL1 TRIM6 ABCC6 CLCA2	6.31e-05	85	112	4	43f6911b032718d8ba75fb7bba5f9b536a4b3260
ToppCell	NS-critical-d_07-13-Myeloid-Mast_cell\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	GFRA3 FBLN2 TIE1 NMT2 CACNA1H	6.46e-05	167	112	5	8a14fd980d8ebe8ef0216221f619d31aaa27ff15
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MAGEA10 GPRIN3 ONECUT1 SULF2 CACNA1H	6.65e-05	168	112	5	8e9046b661642293eee640ead91d43db9d8daae0
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CENPF INSC ASPM POLQ KNL1	6.65e-05	168	112	5	d35944fd9fea9934ce1e76b2b35d48e2300cca61
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)-Glut_ET_L5_FEZF2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MAGEA10 GPRIN3 ONECUT1 SULF2 CACNA1H	6.65e-05	168	112	5	c7d66e5d9311ceaab3f144f1516b49b8812976b8
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CENPF ASPM POLQ KNL1 DNMT1	6.83e-05	169	112	5	b253a4a50c06d36228fcd5d856c57202cbac158f
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CENPF ASPM POLQ FMNL1 KNL1	6.83e-05	169	112	5	54b13ab02b4c187f4754045ecfcf409749e7ccc0
ToppCell	390C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	DTNA ABCC6 ZNF490 CLEC4E ADGRL2	7.03e-05	170	112	5	a6fa0cab1fa829ec601fe48306b4c43c83425b04
ToppCell	390C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	DTNA ABCC6 ZNF490 CLEC4E ADGRL2	7.03e-05	170	112	5	b40255eee45eb18b5a297336d7f3845fd8f8aa3b
ToppCell	5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DLG5 DSC3 DSG3 CROT CLCA2	7.03e-05	170	112	5	0cc20322cb3e3e7bbd4daad8785c99f80e355c16
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	GPRIN3 TAB2 SFXN1 CCSER2 SOS1	7.03e-05	170	112	5	adb625124832b0786a590e8f75b61e7263a1e0d4
ToppCell	5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DLG5 DSC3 DSG3 CROT CLCA2	7.03e-05	170	112	5	2d880223d01bde4bf777bd6f50b7d2768489075f
ToppCell	PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SP100 CENPF TRIM6 CLEC4E FMNL1	7.23e-05	171	112	5	6e7ade1d14a3ec4c566476aac3eb509bd2661e39
ToppCell	PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CENPF F7 SULF2 ASPM KNL1	7.23e-05	171	112	5	845f312f8cbe29d820da25f0e6d75deb382bbfd8
ToppCell	droplet-Trachea-3m-Hematologic-myeloid-granulocyte-\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PPEF1 F7 CLEC4E ASPM POLQ	7.23e-05	171	112	5	41932c9e70829ee3d55ca5fdb74d290fc8229416
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CENPF ASPM POLQ FMNL1 KNL1	7.23e-05	171	112	5	55c7bf7211587fa08df13c0a4ff5b78a85d5439e
ToppCell	AT1-AT2_cells-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	CAPN9 ITGA3 TRIM6 CACNA1H PHLDB2	7.43e-05	172	112	5	0be41df5d35d818deb7316ac21c9366eb4b7bfd1
ToppCell	10x5'-bone_marrow-Lymphocytic_NK-Cycling_NK\|bone_marrow / Manually curated celltypes from each tissue	CENPF ASPM POLQ KNL1 DNMT1	7.63e-05	173	112	5	8a9dd85f718564c07cf3120ad648daeb60c94fc5
ToppCell	PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CENPF F7 SULF2 ASPM KNL1	7.84e-05	174	112	5	65147b0f8c2ccadd5685430d31081520c157536a
ToppCell	BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CENPF EBF1 FBLN2 ASPM KNL1	8.06e-05	175	112	5	553e68e8b439a2293efb969e1e2aa017ceb80daf
ToppCell	Club-club-15\|World / Class top	CENPF KDM5C SULF2 ASPM KNL1	8.06e-05	175	112	5	ca9d012f520f697c7450ec6958a015e20538a6a8
ToppCell	TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma-3\|TCGA-Cervix / Sample_Type by Project: Shred V9	DSC3 DSG3 CROT CLCA2 FRMD6	8.06e-05	175	112	5	0cc215109d9915af47e4d0a120ce2e46910715fa
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CENPF FBLN2 TIE1 ASPM KNL1	8.06e-05	175	112	5	d43ae33a6256606ce848247cad32d74f21b38988
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CENPF KRT39 CLCA2 FRMD6 ASPM	8.06e-05	175	112	5	9142ed8ca2f1c0c518deb21988221406f62fe38c
ToppCell	BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	CENPF EBF1 FBLN2 ASPM KNL1	8.06e-05	175	112	5	16d4e97271df1db9a0d167fc82a90d84d20dd1f2
ToppCell	BAL-Control-Lymphocyte-T/NK-Other_T\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	CENPF EBF1 FBLN2 ASPM KNL1	8.06e-05	175	112	5	289d2aa7164bc02b1876b99f2fb67baa8e030c4e
ToppCell	E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HCAR2 F7 CLEC4E SULF2 FMNL1	8.28e-05	176	112	5	6548797336c9f4ca0f38e74a2c629e2a4defa252
ToppCell	saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DSC3 GPRIN3 SFXN1 ASPM PLCG1	8.50e-05	177	112	5	9edfb50856f5e10672ab194ce0076d6a190e64de
ToppCell	PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CENPF EBF3 SPINT2 ASPM KNL1	8.50e-05	177	112	5	a68c3688f12aee22f3cb4049c4bccacbacb0fae6
ToppCell	COPD-Epithelial-Basal\|Epithelial / Disease state, Lineage and Cell class	HCAR2 DSC3 SULT1E1 CLCA2 FRMD6	8.73e-05	178	112	5	441d1dba720141891b11f404744c59834d80e6c5
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_HNRNPA1P46\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GPRIN3 SULF2 ASPM RORB PHLDB2	8.96e-05	179	112	5	c815eb9f760fe4ca7a5e49beb224659f0b864f22
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DTNA EBF1 INSC MYOCD CACNA1H	8.96e-05	179	112	5	dc6cd46fa652b296ddbc41855f6377946d0a4cdc
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CENPF FBLN2 TIE1 ASPM KNL1	9.20e-05	180	112	5	40d4838a0ccb10d5e49266bc8a0037d27b75ccc2
ToppCell	facs-Skin-Skin_Anagen-18m-Epithelial-actively_dividing_stem_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CENPF RBL1 ABCC6 ASPM KNL1	9.69e-05	182	112	5	bc6a120dedc813c58baac1428c39851a07b71ba7
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MAGEA10 DSC3 DSG3 CLCA2 ASPM	9.69e-05	182	112	5	007fa56ed8b91f9af0df2114c00410b2f6cec8b6
ToppCell	RA-13._Vascular_Smooth_Muscle\|RA / Chamber and Cluster_Paper	AKAP6 DTNA EBF1 SPINT2 MYOCD	9.94e-05	183	112	5	818fd886e0188091310825f9145fa53328f2c979
ToppCell	COVID-19-Heart-CM_4\|COVID-19 / Disease (COVID-19 only), tissue and cell type	AKAP6 DTNA C1orf105 RORB MYOCD	9.94e-05	183	112	5	2902b6e8aa9a6f62bc1a792c971ab7f651a8e676
ToppCell	Control-T/NK-proliferating_T/NK\|Control / Disease group,lineage and cell class （2021.01.30）	CENPF EBF1 FBLN2 ASPM KNL1	9.94e-05	183	112	5	e740f05536d1e4b2512811771928eb65f6696409
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DTNA PCDHB5 GFRA3 INSC CHAC1	9.94e-05	183	112	5	8330c39184ce076e1f95fd3725b68af551d89db0
ToppCell	3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GFRA3 FBLN2 FRMD6 INSC TMEM178B	1.02e-04	184	112	5	226ccac00ac1c3a0ad7283785fd14312320e0ca6
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	AKAP6 ACACB DTNA MYOCD TMEM178B	1.02e-04	184	112	5	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CENPF PPEF1 INSC ASPM KNL1	1.02e-04	184	112	5	d1e0e3b0eed2db8a5b7e3d6f81294667e4ba64e5
ToppCell	droplet-Lung-LUNG-30m-Myeloid-Proliferating_Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RBL1 F7 ASPM POLQ DNMT1	1.02e-04	184	112	5	16aa8e88bdd51b1d132d5cf33c29963b384a8bae
ToppCell	5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DLG5 DSC3 DSG3 CROT CLCA2	1.05e-04	185	112	5	e0172e0ab0f1d7151a3c3c63bb7c84d6bda92035
ToppCell	wk_15-18-Epithelial-PNS-MFNG+_DBH+_neuron\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	MYT1L EBF3 PPEF1 RORB CHAC1	1.07e-04	186	112	5	72f7427d62d65e37bb0bf99229a1b75df081a128
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CENPF GPRIN3 ASPM POLQ KNL1	1.07e-04	186	112	5	993c58ef4445bf81bbc9b489635883848b5b4c8e
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_vein\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SULT1E1 SULF2 TIE1 TMEM178B ADGRL2	1.10e-04	187	112	5	e35716f8b482be3bf5ab79f087a9caf67a9d197a
ToppCell	10x5'-Lung-Mast\|Lung / Manually curated celltypes from each tissue	GFRA3 FBLN2 TIE1 WSCD2 WNK3	1.10e-04	187	112	5	f8ac5ca5cbe9c6f3d8c0fffc20fe08ca1aea43c0
Drug	Rolitetracycline [751-97-3]; Down 200; 7.6uM; HL60; HT_HG-U133A	AMFR DSC3 DTNA INPP5K RAD54L2 DUS2 SRRT CROT CHAC1	5.77e-07	197	112	9	3031_DN
Drug	Isoetharine mesylate salt [7279-75-6]; Up 200; 12uM; PC3; HT_HG-U133A	AMFR ACACB DSG3 OAS3 OGDH LIG3 MFN2 SOS1	4.97e-06	192	112	8	5812_UP
Drug	Tribenoside [10310-32-4]; Down 200; 8.4uM; PC3; HT_HG-U133A	AMFR DHX57 OAS3 TAB2 ZSCAN32 USP5 ATAD2B SOS1	5.79e-06	196	112	8	6328_DN
Drug	fluphenazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A	ANKFY1 DYNC2H1 INPP5K ARHGEF11 DUS2 ATAD2B MFN2 POLQ	5.79e-06	196	112	8	1662_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	SP100 DTNA DIDO1 RAD54L2 ARHGEF11 USP5 NMT2 SOS1	6.01e-06	197	112	8	6222_DN
Drug	LY 294002; Down 200; 10uM; HL60; HT_HG-U133A	RAD54L2 SFXN1 SRRT USP5 MDN1 TTLL4 FMNL1 CHAC1	6.01e-06	197	112	8	1180_DN
Drug	chlorpromazine hydrochloride; Down 200; 1uM; HL60; HT_HG-U133A	DTNA RAD54L2 DUS2 LIG3 CLEC4E USP5 DBR1 CHAC1	6.23e-06	198	112	8	1158_DN
Drug	wortmannin from Penicillium funiculosum; Down 200; 0.01uM; HL60; HT_HG-U133A	DIDO1 DHX57 LIG3 CLEC4E USP5 TTLL4 KIF5B CHAC1	6.23e-06	198	112	8	1184_DN
Drug	Talampicillin hydrochloride [39878-70-1]; Down 200; 7.8uM; PC3; HT_HG-U133A	ANKFY1 ACACB RBL1 KDM5C INPP5K SRRT SFXN3 CHAC1	6.47e-06	199	112	8	7254_DN
Drug	isocinchomeronic acid	OGDH SULT1E1 PLOD1	3.20e-05	13	112	3	CID000007493
Drug	prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A	AMFR ACACB ADGRL1 DUS2 LIG3 CCSER2 PLCG1	3.44e-05	183	112	7	6547_UP
Drug	Trifluridine [70-00-8]; Down 200; 13.6uM; HL60; HT_HG-U133A	ANKFY1 CENPF INPP5K DIDO1 SRRT ASPM SOS1	4.52e-05	191	112	7	6136_DN
Drug	Talampicillin hydrochloride [39878-70-1]; Down 200; 7.8uM; MCF7; HT_HG-U133A	SP100 DYNC2H1 RBL1 INPP5K ADGRL1 TTLL4 SFXN3	4.82e-05	193	112	7	7014_DN
Drug	Sulfamonomethoxine [1220-83-3]; Down 200; 14.2uM; HL60; HT_HG-U133A	DYNC2H1 INPP5K PCNX2 LIG3 USP5 CCSER2 PLCG1	4.98e-05	194	112	7	2742_DN
Drug	5230742; Up 200; 17uM; MCF7; HT_HG-U133A_EA	AKAP6 DYNC2H1 RBL1 ARHGEF11 PCNX2 ZSCAN32 MTARC2	4.98e-05	194	112	7	862_UP
Drug	0179445-0000 [211246-22-9]; Down 200; 1uM; MCF7; HT_HG-U133A	SP100 KDM5C ADGRL1 OGDH ZSCAN32 C1orf105 MTARC2	4.98e-05	194	112	7	4758_DN
Drug	Alexidine dihydrochloride [22573-93-9]; Down 200; 6.8uM; MCF7; HT_HG-U133A	DHX57 RAD54L2 SFXN3 MFN2 PLCG1 PRMT7 POLQ	4.98e-05	194	112	7	4721_DN
Drug	Skimmianine [83-95-4]; Down 200; 15.4uM; HL60; HT_HG-U133A	DTNA TAB2 LIG3 ZSCAN32 PRMT7 CHAC1 SOS1	4.98e-05	194	112	7	2504_DN
Drug	Pyrithyldione [77-04-3]; Down 200; 24uM; HL60; HT_HG-U133A	DYNC2H1 INPP5K PCNX2 USP5 NMT2 CCSER2 SOS1	5.15e-05	195	112	7	2740_DN
Drug	Calycanthine [595-05-1]; Down 200; 11.6uM; MCF7; HT_HG-U133A	CAPN9 AMFR ANKFY1 DTNA MFN2 CHAC1 SOS1	5.32e-05	196	112	7	2764_DN
Drug	Domperidone maleate; Down 200; 7.4uM; HL60; HT_HG-U133A	CENPF KDM5C RAD54L2 OGDH USP5 SFXN3 FMNL1	5.32e-05	196	112	7	1301_DN
Drug	Betonicine [515-25-3]; Up 200; 25.2uM; HL60; HT_HG-U133A	AKAP6 DLG5 TMPRSS15 INPP5K SRRT CLEC4E USP5	5.32e-05	196	112	7	2207_UP
Drug	Labetalol hydrochloride [32780-64-6]; Down 200; 11uM; MCF7; HT_HG-U133A	SP100 ACACB RBL1 KDM5C ADGRL1 USP5 PRMT7	5.32e-05	196	112	7	3167_DN
Drug	PNU-0251126 [267429-19-6]; Down 200; 1uM; MCF7; HT_HG-U133A	CAPN9 DSC3 DTNA INPP5K ZSCAN32 MFN2 CACNA1H	5.49e-05	197	112	7	4714_DN
Drug	Racecadotril [81110-73-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A	AMFR SP100 RBL1 DHX57 USP5 NMT2 SOS1	5.49e-05	197	112	7	6231_DN
Drug	Pimozide [2062-78-4]; Down 200; 8.6uM; PC3; HT_HG-U133A	ANKFY1 DSC3 RBL1 DIDO1 HMGCR ARHGEF11 PRMT7	5.49e-05	197	112	7	7132_DN
Drug	Amidopyrine [58-15-1]; Down 200; 17.2uM; MCF7; HT_HG-U133A	ANKFY1 INPP5K OAS3 SRRT ZSCAN32 USP5 CHAC1	5.49e-05	197	112	7	2222_DN
Drug	Fenofibrate [49562-28-9]; Up 200; 11uM; MCF7; HT_HG-U133A	CAPN9 DLG5 SP100 ADGRL1 RAD54L2 CACNA1H CHAC1	5.49e-05	197	112	7	7474_UP
Drug	Procaine hydrochloride [51-05-8]; Down 200; 14.6uM; PC3; HT_HG-U133A	RBL1 ADGRL1 RAD54L2 CCSER2 DBR1 CHAC1 SOS1	5.49e-05	197	112	7	1796_DN
Drug	Folic acid [59-30-3]; Down 200; 9uM; MCF7; HT_HG-U133A	TMPRSS15 DTNA KDM5C SRRT ZSCAN32 PLCG1 PRMT7	5.49e-05	197	112	7	2783_DN
Drug	Fludrocortisone acetate [514-36-3]; Up 200; 9.4uM; MCF7; HT_HG-U133A	CAPN9 ACACB DTNA SRRT CLEC4E CROT CPLANE1	5.49e-05	197	112	7	2328_UP
Drug	Pargyline hydrochloride [306-07-0]; Down 200; 20.4uM; MCF7; HT_HG-U133A	DLG5 DTNA ADGRL1 SRRT LIG3 MFN2 CACNA1H	5.49e-05	197	112	7	2265_DN
Drug	Saquinavir mesylate [149845-06-7]; Down 200; 5.2uM; PC3; HT_HG-U133A	TMPRSS15 ANKFY1 CENPF DUS2 USP5 NMT2 SFXN3	5.49e-05	197	112	7	5770_DN
Drug	2-propylpentanoic acid; Down 200; 500uM; MCF7; HT_HG-U133A	DTNA SRRT LIG3 USP5 MFN2 MTARC2 SOS1	5.49e-05	197	112	7	6999_DN
Drug	Gentamicine sulfate [1405-41-0]; Down 200; 2.6uM; PC3; HT_HG-U133A	AMFR INPP5K DIDO1 ZSCAN32 KIF5B CHAC1 SOS1	5.49e-05	197	112	7	2082_DN
Drug	Deptropine citrate [2169-75-7]; Down 200; 7.6uM; MCF7; HT_HG-U133A	TMPRSS15 KDM5C PCNX2 NMT2 TTLL4 MFN2 PLCG1	5.67e-05	198	112	7	5543_DN
Drug	Bemegride [64-65-3]; Down 200; 25.8uM; PC3; HT_HG-U133A	SP100 ACACB TAB2 ARHGEF11 USP5 CPLANE1 CHAC1	5.67e-05	198	112	7	6668_DN
Drug	Chlorthalidone [77-36-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A	ANKFY1 ACACB DTNA KDM5C OAS3 RAD54L2 SFXN3	5.67e-05	198	112	7	3198_DN
Drug	N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; MCF7; HT_HG-U133A	CAPN9 ACACB DSC3 RAD54L2 NMT2 SFXN3 CACNA1H	5.67e-05	198	112	7	6031_DN
Drug	Bucladesine sodium salt [16980-89-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A	DTNA KDM5C INPP5K ADGRL1 OGDH SRRT SFXN3	5.67e-05	198	112	7	3483_DN
Drug	Amrinone [60719-84-8]; Down 200; 21.4uM; HL60; HT_HG-U133A	AMFR DTNA KDM5C INPP5K ARHGEF11 NMT2 ATAD2B	5.67e-05	198	112	7	2724_DN
Drug	Halcinonide [3093-35-4]; Down 200; 8.8uM; MCF7; HT_HG-U133A	DSC3 KDM5C LIG3 NMT2 SFXN3 CACNA1H PRMT7	5.67e-05	198	112	7	6040_DN
Drug	Trimethylcolchicinic acid [3482-37-9]; Down 200; 11.6uM; MCF7; HT_HG-U133A	AMFR DTNA DIDO1 ZSCAN32 NMT2 TTLL4 PLCG1	5.85e-05	199	112	7	2802_DN
Drug	Picotamide monohydrate [80530-63-8]; Down 200; 10.2uM; PC3; HT_HG-U133A	ACACB DIDO1 PCNX2 USP5 TTLL4 SFXN3 PRMT7	5.85e-05	199	112	7	7140_DN
Drug	Ticarcillin sodium [4697-14-7]; Up 200; 9.4uM; MCF7; HT_HG-U133A	ANKFY1 RBL1 DTNA SRRT LIG3 SFXN3 DBR1	5.85e-05	199	112	7	7185_UP
Drug	Kawain [500-64-1]; Up 200; 17.4uM; HL60; HT_HG-U133A	TMPRSS15 DYNC2H1 ARHGEF11 PCNX2 ZSCAN32 CCSER2 SOS1	5.85e-05	199	112	7	2337_UP
Drug	Thiethylperazine malate [52239-63-1]; Down 200; 6uM; HL60; HT_HG-U133A	DTNA DIDO1 SRRT USP5 CCSER2 PLCG1 SNTB2	5.85e-05	199	112	7	6154_DN
Drug	Nimodipine [66085-59-4]; Down 200; 9.6uM; MCF7; HT_HG-U133A	CAPN9 AMFR TMPRSS15 CENPF INPP5K LIG3 SFXN3	5.85e-05	199	112	7	6480_DN
Drug	Cefalonium [5575-21-3]; Up 200; 8.8uM; HL60; HT_HG-U133A	TMPRSS15 ACACB OAS3 CLEC4E CROT C1orf105 ADGRL2	5.85e-05	199	112	7	2921_UP
Drug	Lidoflazine [3416-26-0]; Down 200; 8.2uM; MCF7; HT_HG-U133A	RBL1 DTNA KDM5C INPP5K ADGRL1 LIG3 MTARC2	6.04e-05	200	112	7	6278_DN
Drug	Urosiol [128-13-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A	DSC3 KDM5C ADGRL1 SFXN3 PLCG1 CHAC1 SOS1	6.04e-05	200	112	7	6484_DN
Drug	Acetylsalicylsalicylic acid [530-75-6]; Down 200; 13.4uM; PC3; HT_HG-U133A	AMFR DLG5 ADGRL1 ARHGEF11 PCNX2 TTLL4 PRMT7	6.04e-05	200	112	7	2061_DN
Drug	tetratriacontane	ABCC6 SULT1E1	7.17e-05	3	112	2	CID000026519
Drug	nonacosane	ABCC6 SULT1E1	7.17e-05	3	112	2	CID000012409
Drug	heptacosane	ABCC6 SULT1E1	7.17e-05	3	112	2	CID000011636
Drug	AC1L1BJ8	DSC3 DSG3 CYP21A2 ABCC6	8.41e-05	47	112	4	CID000001462
Drug	black widow spider venom	ADGRL1 ADGRL2	1.43e-04	4	112	2	ctd:C038599
Drug	alpha-latrotoxin	ADGRL1 ADGRL2	1.43e-04	4	112	2	ctd:C020763
Drug	hexacosane	ABCC6 SULT1E1	1.43e-04	4	112	2	CID000012407
Drug	heneicosane	ABCC6 SULT1E1	1.43e-04	4	112	2	CID000012403
Drug	tritriacontane	ABCC6 SULT1E1	1.43e-04	4	112	2	CID000012411
Drug	pentatriacontane	ABCC6 SULT1E1	1.43e-04	4	112	2	CID000012413
Drug	AC1L1CR9	RBL1 AGPS PLCG1	1.44e-04	21	112	3	CID000002023
Drug	hentriacontane	ABCC6 SULT1E1	2.38e-04	5	112	2	CID000012410
Drug	Rifabutin [72559-06-9]; Down 200; 4.8uM; MCF7; HT_HG-U133A	DTNA DIDO1 OAS3 OGDH SRRT LIG3	3.02e-04	184	112	6	4349_DN
Drug	Etoposide [33419-42-0]; Down 200; 6.8uM; MCF7; HT_HG-U133A	CENPF RBL1 DTNA ASPM MTARC2 CHAC1	3.11e-04	185	112	6	3241_DN
Drug	Texas Red	DSG3 ADGRL1 ABCC6	3.47e-04	28	112	3	CID000452705
Drug	N-(1-naphthyl)ethylenediamine	TMPRSS15 DSG3	3.55e-04	6	112	2	CID000015106
Drug	tricosane	ABCC6 SULT1E1	3.55e-04	6	112	2	CID000012534
Drug	octacosane	ABCC6 SULT1E1	3.55e-04	6	112	2	CID000012408
Drug	2-propylpentanoic acid; Down 200; 1000uM; HL60; HT_HG-U133A	KDM5C DIDO1 OGDH SRRT LIG3 ATAD2B	3.59e-04	190	112	6	1150_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	ANKFY1 TAB2 ARHGEF11 SRRT MFN2 SOS1	3.59e-04	190	112	6	6709_DN
Drug	Tolbutamide [64-77-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A	DTNA INPP5K ARHGEF11 SRRT NMT2 PLCG1	3.59e-04	190	112	6	4362_DN
Drug	Convolamine hydrochloride [500-56-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A	DTNA ZSCAN32 CROT NMT2 TTLL4 SFXN3	3.69e-04	191	112	6	2771_UP
Drug	17-DMAG; Down 200; 0.1uM; MCF7; HT_HG-U133A	INPP5K ADGRL1 RAD54L2 C1orf105 SFXN3 PLCG1	3.69e-04	191	112	6	5210_DN
Drug	fluphenazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A	DTNA ADGRL1 RAD54L2 ARHGEF11 MFN2 PLCG1	3.69e-04	191	112	6	5234_DN
Drug	Dorzolamide hydrochloride [130693-82-2]; Down 200; 11uM; HL60; HT_HG-U133A	ANKFY1 DTNA SRRT LIG3 MFN2 SNTB2	3.69e-04	191	112	6	6142_DN
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	KDM5C INPP5K ARHGEF11 TTLL4 CCSER2 PLCG1	3.69e-04	191	112	6	6944_DN
Drug	Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA	SP100 KDM5C INPP5K CCSER2 MFN2 PLCG1	3.69e-04	191	112	6	1080_UP
Drug	Nitrofural [59-87-0]; Down 200; 20.2uM; PC3; HT_HG-U133A	INPP5K RAD54L2 SRRT MFN2 CHAC1 SOS1	3.69e-04	191	112	6	6721_DN
Drug	rottlerin; Down 200; 10uM; MCF7; HT_HG-U133A_EA	DYNC2H1 RBL1 KDM5C ARHGEF11 CROT POLQ	3.69e-04	191	112	6	941_DN
Drug	Albendazole [54965-21-8]; Down 200; 15uM; MCF7; HT_HG-U133A	SP100 ACACB RBL1 RAD54L2 ARHGEF11 ZSCAN32	3.79e-04	192	112	6	3164_DN
Drug	Resveratrol [501-36-0]; Down 200; 17.6uM; MCF7; HT_HG-U133A	TMPRSS15 CENPF DIDO1 USP5 ASPM PLCG1	3.79e-04	192	112	6	5509_DN
Drug	Metoclopramide monohydrochloride [7232-21-5]; Down 200; 11.8uM; PC3; HT_HG-U133A	DLG5 ADGRL1 ARHGEF11 SFXN3 PLCG1 CHAC1	3.90e-04	193	112	6	4285_DN
Drug	Epitiostanol [2363-58-8]; Up 200; 13uM; MCF7; HT_HG-U133A	PCNX2 FZD9 ZSCAN32 TTLL4 CHAC1 SOS1	3.90e-04	193	112	6	4788_UP
Drug	Testosterone propionate [57-85-2]; Up 200; 11.6uM; MCF7; HT_HG-U133A	DLG5 SP100 PCNX2 PLCG1 CPLANE1 CHAC1	3.90e-04	193	112	6	5271_UP
Drug	Progesterone [57-83-0]; Down 200; 12.8uM; PC3; HT_HG-U133A	SP100 ACACB INPP5K DUS2 USP5 CCSER2	3.90e-04	193	112	6	6646_DN
Drug	Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; MCF7; HT_HG-U133A	ANKFY1 ARHGEF11 SRRT C1orf105 MFN2 CHAC1	3.90e-04	193	112	6	3624_DN
Drug	0297417-0002B [362658-29-5]; Down 200; 10uM; PC3; HT_HG-U133A	ACACB DTNA RAD54L2 DUS2 LIG3 POLQ	4.01e-04	194	112	6	6895_DN
Drug	Etanidazole [22668-01-5]; Down 200; 18.6uM; MCF7; HT_HG-U133A	ACACB DTNA INPP5K ADGRL1 PCNX2 PLCG1	4.01e-04	194	112	6	6072_DN
Drug	Thonzonium bromide [553-08-2]; Down 200; 6.8uM; PC3; HT_HG-U133A	SP100 ANKFY1 CENPF RBL1 SRRT ATAD2B	4.01e-04	194	112	6	4617_DN
Drug	Decamethonium bromide [541-22-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A	DTNA ADGRL1 RAD54L2 ONECUT1 CLEC4E DBR1	4.01e-04	194	112	6	4174_DN
Drug	PHA-00745360 [351320-33-7]; Down 200; 10uM; PC3; HT_HG-U133A	ACACB KDM5C ADGRL1 ARHGEF11 PCNX2 LIG3	4.01e-04	194	112	6	4559_DN
Drug	ICI 182,780; Up 200; 1uM; HL60; HT_HG-U133A	AMFR DTNA ADGRL1 ARHGEF11 CROT C1orf105	4.01e-04	194	112	6	1146_UP
Drug	Strophanthidin [66-28-4]; Down 200; 9.8uM; PC3; HT_HG-U133A	DLG5 ADGRL1 ARHGEF11 DUS2 ZSCAN32 TTLL4	4.01e-04	194	112	6	5826_DN
Drug	Cyproterone acetate [427-51-0]; Down 200; 9.6uM; HL60; HT_HG-U133A	DHX57 DUS2 SRRT ZSCAN32 CLEC4E CCSER2	4.01e-04	194	112	6	6124_DN
Drug	Lynestrenol [52-76-6]; Up 200; 14uM; MCF7; HT_HG-U133A	ADGRL1 OAS3 RAD54L2 SFXN3 PLCG1 CHAC1	4.01e-04	194	112	6	5355_UP
Drug	Acyclovir [59277-89-3]; Down 200; 17.8uM; MCF7; HT_HG-U133A	DLG5 ACACB CENPF ADGRL1 ARHGEF11 PLCG1	4.01e-04	194	112	6	5278_DN
Drug	Omeprazole [73590-58-6]; Down 200; 11.6uM; HL60; HT_HG-U133A	ANKFY1 DYNC2H1 ARHGEF11 NMT2 TTLL4 DBR1	4.01e-04	194	112	6	2467_DN
Drug	Cefixime [79350-37-1]; Down 200; 8.8uM; HL60; HT_HG-U133A	ANKFY1 DYNC2H1 INPP5K SRRT CCSER2 SOS1	4.01e-04	194	112	6	1310_DN
Disease	propionylglycine measurement	CYP21A2 UHRF2	1.37e-04	5	110	2	EFO_0800207
Disease	phospholipase B-like 1 measurement	MFN2 PLOD1	1.37e-04	5	110	2	EFO_0802865
Disease	splicing factor 3B subunit 4 measurement	MFN2 PLOD1	1.37e-04	5	110	2	EFO_0803100
Disease	muscular disease (implicated_via_orthology)	ACACB NMT2	1.37e-04	5	110	2	DOID:0080000 (implicated_via_orthology)
Disease	ETS domain-containing protein Elk-3 measurement	MFN2 PLOD1	2.05e-04	6	110	2	EFO_0801588
Disease	WAP four-disulfide core domain protein 3 measurement	MFN2 PLOD1	2.05e-04	6	110	2	EFO_0802220
Disease	acid ceramidase measurement	MFN2 PLOD1	2.05e-04	6	110	2	EFO_0801339
Disease	lon protease homolog, mitochondrial measurement	MFN2 PLOD1	2.05e-04	6	110	2	EFO_0801771
Disease	X-16570 measurement	CYP21A2 UHRF2	2.05e-04	6	110	2	EFO_0800759
Disease	gamma-glutamylglycine measurement	CYP21A2 UHRF2	2.86e-04	7	110	2	EFO_0800670
Disease	interleukin-17 receptor B measurement	MFN2 PLOD1	2.86e-04	7	110	2	EFO_0801719
Disease	Duchenne muscular dystrophy (implicated_via_orthology)	CAPN9 DTNA SNTB2	3.29e-04	36	110	3	DOID:11723 (implicated_via_orthology)
Disease	stromal cell-derived factor 1 alpha measurement	CYP21A2 GPRIN3 SPINT2	5.58e-04	43	110	3	EFO_0008293
Disease	ovary epithelial cancer (is_implicated_in)	AKAP6 TAB2	7.41e-04	11	110	2	DOID:2152 (is_implicated_in)
Disease	cystatin C measurement	CYP21A2 ZKSCAN8 RDH14 FZD9 USP5 XPO5 SOS1	7.90e-04	402	110	7	EFO_0004617
Disease	motor neuron disease (implicated_via_orthology)	VAPA KIF5B	8.87e-04	12	110	2	DOID:231 (implicated_via_orthology)
Disease	Polydactyly	CENPF DYNC2H1 SPINT2 CPLANE1	9.81e-04	117	110	4	C0152427
Disease	body mass index, osteoarthritis	WSCD2 CACNA1H SNTB2	1.09e-03	54	110	3	EFO_0004340, MONDO_0005178
Disease	phenylalanine measurement	VAPA CYP21A2 ABCC6	1.15e-03	55	110	3	EFO_0005001
Disease	N-acetylglycine measurement	CYP21A2 UHRF2	1.22e-03	14	110	2	EFO_0021002
Disease	Autosomal recessive primary microcephaly	ASPM KNL1	1.40e-03	15	110	2	cv:C3711387
Disease	Stevens-Johnson syndrome, toxic epidermal necrolysis, response to anticonvulsant	DDX12P TAB2	1.60e-03	16	110	2	EFO_0004276, EFO_0004775, GO_0036277
Disease	primary autosomal recessive microcephaly (is_implicated_in)	ASPM KNL1	1.60e-03	16	110	2	DOID:0070296 (is_implicated_in)
Disease	protein C measurement	FZD9 FRMD6	1.81e-03	17	110	2	EFO_0004633
Disease	non-alcoholic fatty liver disease (biomarker_via_orthology)	ACACB HMGCR MFN2	1.86e-03	65	110	3	DOID:0080208 (biomarker_via_orthology)
Disease	cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement	AMFR CYP21A2 HMGCR OGDH	2.10e-03	144	110	4	EFO_0004611, EFO_0020943
Disease	susceptibility to chronic sinus infection measurement	CENPF EBF1 UHRF2	2.12e-03	68	110	3	EFO_0008419
Disease	Malignant neoplasm of breast	AKAP6 AMFR DSC3 CENPF DYNC2H1 INPP5K SULF2 CLCA2 TEKT4 PLOD1 DNMT1	2.26e-03	1074	110	11	C0006142
Disease	cardiomyopathy (is_implicated_in)	DTNA TAB2	2.26e-03	19	110	2	DOID:0050700 (is_implicated_in)
Disease	cerebral infarction (is_marker_for)	F7 SOS1	2.26e-03	19	110	2	DOID:3526 (is_marker_for)
Disease	TNF-related apoptosis-inducing ligand measurement	DSG3 DTNA CROT	2.49e-03	72	110	3	EFO_0008300
Disease	coagulation factor measurement	F7 ASPM	2.50e-03	20	110	2	EFO_0004634
Disease	serum homoarginine measurement	CYP21A2 UHRF2	2.50e-03	20	110	2	EFO_0005421
Disease	atrial fibrillation	AKAP6 CYP21A2 TAB2 SULF2 MYOCD PHLDB2	2.71e-03	371	110	6	EFO_0000275
Disease	intellectual disability (implicated_via_orthology)	CAPN9 RBL1 KDM5C	2.80e-03	75	110	3	DOID:1059 (implicated_via_orthology)
Disease	forced expiratory volume	VAPA RDH14 EBF1 ONECUT1 FZD9 ATAD2B TMEM178B ADGRL2 CHAC1	2.81e-03	789	110	9	EFO_0004314
Disease	Autosomal Recessive Primary Microcephaly	ASPM KNL1	3.03e-03	22	110	2	C3711387
Disease	Primary microcephaly	ASPM KNL1	3.03e-03	22	110	2	C0431350
Disease	prostate cancer, disease progression measurement	EBF3 F7	3.60e-03	24	110	2	EFO_0008336, MONDO_0008315
Disease	Hodgkins lymphoma	DDX12P KRT39 CPLANE1	3.60e-03	82	110	3	EFO_0000183

Protein segments in the cluster

Peptide	Gene	Start	Entry
LRCVFEMPNENDKLN	VAPA	126	Q9P0L0
RSKQACQERRCPNMA	DNMT1	681	P26358
PDAFKIMSQRCNNRT	ADGRL1	86	O94910
FMQEAESHPQCRRLQ	ARHGEF11	856	O15085
LPDAFKIMTQRCNNR	ADGRL2	86	O95490
SNMFERPILNGQCID	RAD54L2	521	Q9Y4B4
RNLLRNPCAEEDMFA	FBXO6	86	Q9NRD1
DRVRSPLQACENLAM	ASPM	186	Q8IZT6
LSRNADPNVACRRLM	ASZ1	136	Q8WWH4
DNGRMICSIQNDLPF	PCDHB5	376	Q9Y5E4
VMCRFRPLNESEVNR	KIF5B	11	P33176
ELNRMRNFDLTAVPC	ACACB	1501	O00763
NVRDRQGLTPFACAM	ANKFY1	831	Q9P2R3
LVLTDSQNNRCEMPR	DSG3	566	P32926
SQNNRCEMPRSLTLE	DSG3	571	P32926
MDNVNFCNPSVLDRL	MDN1	2241	Q9NU22
KRQRCMPEEDLQSQS	MAGEA10	6	P43363
RAMELLSACQGPARN	NMT2	96	O60551
APSADLNQVLQEMRC	KRT39	256	Q6A163
MNSPCDRLQQFIQVL	ERVFC1-1	1	P60608
RCLQRKMTGEPDNNR	HCAR2	311	Q8TDS4
DNCCRREPMLVRNNQ	HMGCR	366	P04035
ARNRCLPMNFRAEDL	ATAD2B	356	Q9ULI0
ADVPLLSNERCQQQM	TMPRSS15	931	P98073
QLTQEFCERMRAQPG	CYP21A2	141	P08686
QARQRCMDGFLQDPE	FBLN2	791	P98095
PSNNDCLSQAREMQV	PCNX2	731	A6NKB5
FCELGNPFKRNQRME	ITGA3	701	P26006
EPEFQRMSALRLAAC	ONECUT1	356	Q9UBC0
MEPQRRELLAQCQQS	DLG5	1	Q8TDM6
QTCNQDARILAMTPE	KNL1	426	Q8NG31
SRIFNCNPDDMARDL	LIG3	331	P49916
ALMDRLRPFQDCSGN	MYOCD	396	Q8IZQ8
SQIDMLVPRQCFSLN	MFN2	511	O95140
KLDPDMAFCANIRQQ	PLOD1	476	Q02809
SSARPERFLQMCNDD	OGDH	791	Q02218
DGCQPLQLLREMRQA	CBY2	351	Q8NA61
LENVECDNMNRFDRP	CCSER2	566	Q9H7U1
CDNMNRFDRPDRNVR	CCSER2	571	Q9H7U1
EQARLRCAPIMEQFN	FZD9	116	O00144
VMQDRRSVCIFLPND	FRMD6	11	Q96NE9
LRPDRLQSAMALFAC	DYNC2H1	3681	Q8NCM8
EKLHRCNQNEDRMPS	DSC3	831	Q14574
RESERNQCNFKPQMD	CENPF	1181	P49454
QLPDCSESVRQMLQD	CPLANE1	2036	Q9H799
MNSCLQARRKCQADP	GFRA3	41	O60609
NERVRQMRPVCDCQA	PRMT7	356	Q9NVM4
CRQNFLSGRVLQEMA	DHX57	1146	Q6P158
VNPRCQAQMEERAAD	POLQ	2291	O75417
RILEMQNCEGRDIPN	INPP5K	166	Q9BT40
RLADFMQLCGPQAQD	CHAC1	181	Q9BUX1
TMQPVSNFRQQLLAC	DDX12P	641	Q92771
VDDLPNRMCADVRRN	DIDO1	1441	Q9BTC0
QNCLKNAGNPRDMRR	EBF1	196	Q9UH73
NCLIFRAPDMDQLVL	MTARC2	121	Q969Z3
NLPCELQRNFQLMRE	ING5	16	Q8WYH8
EERFNRALNCMNLPP	FMNL1	36	O95466
LRNNPSCMLESSNRL	DTNA	416	Q9Y4J8
QPRLVDSFLLCSNME	INSC	561	Q1MX18
QAVRNEADLRCMAVP	DBR1	41	Q9UK59
CQMLREQLESPQGRL	DUS2	286	Q9NX74
QNCLKNAGNPRDMRR	EBF3	196	Q9H4W6
SVFQSMLQNFRRPNC	GPRIN3	751	Q6ZVF9
ENPFICSSRRDNGMQ	CACNA1H	286	O95180
QMRQECLQRGTLFED	CAPN9	31	O14815
CQSMQDPSVNLRERQ	CROT	466	Q9UKG9
ATCFQPLRQRVDTME	PPEF1	456	O14829
ACFAELRRNFMNIRP	OAS3	581	Q9Y6K5
EPQDTLCTRSRQQAM	MROH5	461	Q6ZUA9
QSNVDFDLMLRCRNP	METTL26	151	Q96S19
RLNPCLMELCQFFQQ	HHLA1	461	C9JL84
RQLFAMSPADECSRQ	TMEM178B	86	H3BS89
AANCINIPLMRQREL	SFXN3	186	Q9BWM7
AAANCINIPLMRQRE	SFXN1	186	Q9H9B4
IPSLEEMQQLRSCNR	TAB2	586	Q9NYJ8
ALMCLLDQARQPGDR	ABCC6	846	O95255
LDLIFANAIMCPNRQ	RBL1	206	P28749
NVPRLMTQDCLQQSR	F7	361	P08709
ANEAMCRPIRALTQA	OPLAH	461	O14841
RPNMELCRDAAQFRL	TEKT4	351	Q8WW24
SVRAFCQEMLQEEPR	RDH14	121	Q9HBH5
TQLDNCPESMREQLQ	PHLDB2	691	Q86SQ0
LNMLCQAQPRSASDV	SOS1	56	Q07889
ASMAPQDCLAQLRLA	RHPN1	296	Q8TCX5
CSLFMRNIAPNISRA	SRRT	421	Q9BXP5
RETCNLNADHQPMQL	AKAP6	1151	Q13023
PTCRMSLNIADNNRV	AMFR	376	Q9UKV5
PDVLSKARRNQCDSM	C1orf105	61	O95561
QRCAPASIRLMDNKQ	AGPS	411	O00116
LEDCATMRDSSNPRQ	CLEC4E	176	Q9ULY5
EAPNLQNQMCSLRSA	CLCA2	261	Q9UQC9
TNMNRALALNCDAPL	UHRF2	531	Q96PU4
NLTELDMRFNPFDCT	TLR3	636	O15455
PAMRDNRAVSLCQQE	ZSCAN32	211	Q9NX65
NQGRNLRSPMVEALC	ZNF490	111	Q9ULM2
NRIPFLECRKENLMN	SULT1E1	76	P49888
EFNLETMPRINCAAA	TIE1	361	P35590
GNQVERPQMTFCRLQ	SSX7	91	Q7RTT5
EEACMLRCFRQQENP	SPINT2	176	O43291
RRLNECISPVANEMN	SP100	11	P23497
VRMCRAFNPLNNTVL	RORB	316	Q92753
AQQGEVMRLACRLDP	XPO5	441	Q9HAV4
QVPLRCNEFEMRLSE	PLCG1	641	P19174
MGRLNEQRLFQPDLC	ZBTB47	1	Q9UFB7
QDNRCMDRRFLPGKS	WSCD2	326	Q2TBF2
CFAARNLSMPDLENR	SNTB2	251	Q13425
NRNNLAMRAEPLSCA	TTLL4	306	Q14679
QCNPRTRNMDLGLKD	SULF2	821	Q8IWU5
MVERNCRSSENPNEV	USP5	446	P45974
MEPERCRIQTEFNQL	TRIM6	176	Q9C030
KDLCRDNRPENFRNM	ZKSCAN8	241	Q15776
QNCNDDSLNVALPMR	UBE3C	156	Q15386
RRDSQCKSMGNVFPQ	WNK3	506	Q9BYP7
TELRAFLDQMNNLPC	KDM5C	851	P41229
ILNLSTRCREMPQNL	MYT1L	736	Q9UL68